Pharmacological Treatment of Ocular Inflammatory Diseases

Novel strategies for ocular anti-inflammatory therapies are extensively being investigated to increase drug bioavailability and decrease adverse side effects of common treatments. Colloidal carriers based on lipid materials are becoming a suitable alternative due to several advantages, including solubilization of hydrophobic/lipophilic anti-inflammatory drugs followed by bioavailability enhancement, modification of pharmacokinetic parameters, and protection of sensitive drugs from physical,...